IPHARMA keeps leading positions among the contract research organizations in local clinical trials (Research and information bulletin #14 Association of Clinical Trials Organization ACTO April, 6, 2017) In 2016 IPHARMA got 10 licences for conducting Phases I-III clinical trials in several therapeutic areas: oncology, virology, endocrinology, pulmonology and other. All drugs are innovative assign to local clinical trials market. IPHARMA got registration certificate for SatRx

IPHARMA, a clinical division of the ChemRar/ChemDiv group, is the top contract research organization in terms of the number of local clinical trials of Russian innovative medicines conducted in 2013. This information is published in the latest issue of the Association of Clinical Trials Organizations (ACTO) Newsletter from April 14, 2014. IPHARMA specializes in organizing and conducting clinical trials. In its 2013 analytical report, ACTO amassed data among companies conducti